Document and Entity Information [Abstract] Document and Entity Information [Abstract] Document Type Amendment Flag Document Period End Date Document Fiscal Year Focus Document Fiscal Period Focus Entity Registrant Name Entity Central Index Key Current Fiscal Year End Date Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Filer Category Entity Public Float Trading Symbol Entity Common Stock, Shares Outstanding Entity Shell Company Entity Emerging Growth Company Entity Ex Transition Period Entity Small Business Statement of Financial Position [Abstract] CONSOLIDATED BALANCE SHEETS Statement [Table] Schedule of warrants outstanding to purchase shares of Class A common stock [Table] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Statement [Line Items] Statement Assets [Abstract] ASSETS Assets, Current [Abstract] Current assets: Cash Assets, Current Total current assets Restricted Cash, Current Restricted cash Accounts Receivable, Net, Current Accounts receivable, net Accounts receivable Inventory, Net Inventory Inventory Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Business Combination, Contingent Consideration, Asset Contingent consideration forfeiture rights Fair value of contingent consideration forfeiture rights Assets Total assets Property, Plant and Equipment, Net Property and equipment, net Notes Receivable, Related Parties, Noncurrent Notes receivable from related parties Balance Balance Net principal and interest receivable Intangible Assets, Net (Excluding Goodwill) Intangible assets, net Goodwill Goodwill arising from acquisition Deferred Tax Assets, Net of Valuation Allowance Deferred tax asset Net deferred tax assets Other Assets, Noncurrent Other assets Liabilities and Equity [Abstract] Liabilities, Redeemable Common Stock and Stockholders' Equity (Deficit) Liabilities, Current [Abstract] Current liabilities: Accrued Expenses And Other Current Liabilities Accrued expenses and other current liabilities Accrued expenses and other current liabilities. Liabilities, Current Total current liabilities Redeemable Common Stock Liability Redeemable common stock liability Redeemable common stock liability. Notes Payable, Current Current portion of notes payable Less current maturities Carrying value of notes payable Capital Lease Obligations, Current Current portion of capital lease obligations Less current maturities Accounts Payable, Current Accounts payable Business Combination, Contingent Consideration, Liability, Current Deferred acquisition consideration Business acquisition consideration deferred Liabilities Total liabilities Commitments and Contingencies Commitments and contingencies (Notes 20 and 24) Stockholders' Equity Attributable to Parent [Abstract] Stockholders' equity (deficit): Additional Paid in Capital, Common Stock Additional paid-in capital Retained Earnings (Accumulated Deficit) Accumulated deficit Accumulated deficit Stockholders' Equity Attributable to Parent Total stockholders' equity (deficit) Balance Balance Common Stock, Value, Issued Common stock, $0.0001 par value; 400,000,000 and 81,200,000 shares authorized at December 31, 2018 and 2017, respectively; 91,261,412 and 66,983,138 shares issued and outstanding at December 31, 2018 and 2017, respectively. Liabilities and Equity Total liabilities, redeemable common stock and stockholders' equity (deficit) Long-term Line of Credit, Noncurrent Line of credit Notes Payable, Noncurrent Notes payable, net of current portion Notes payable, net of debt discount Due to Affiliate, Noncurrent Due to affiliates Warrant Liability Warrant liability Warrant liability. Deferred Rent Credit, Noncurrent Deferred rent, net of current portion Capital Lease Obligations, Noncurrent Capital lease obligations, net of current portion Long-term portion Other Liabilities, Noncurrent Other liabilities Temporary Equity, Carrying Amount, Attributable to Parent Redeemable common stock, $0.0001 par value; 728,549 shares issued and outstanding at December 31, 2018 and 2017. Other Long-term Debt, Noncurrent Long-term debt - affiliates Temporary Equity, Par or Stated Value Per Share Redeemable common stock, par value Temporary Equity, Shares Issued Redeemable common stock, shares issued Temporary Equity, Shares Outstanding Redeemable common stock, shares outstanding Common Stock, Par or Stated Value Per Share Common stock, par value Commoon stock par value Common shares, par value (in dollar per share) Common Stock, Shares Authorized Common stock, shares authorized Common Shares, Shares Authorized Common Stock, Shares, Issued Common stock, shares issued Common Stock, Shares, Outstanding Common stock, shares outstanding Balance (in shares) Balance (in shares) Income Statement [Abstract] CONSOLIDATED STATEMENTS OF OPERATIONS Operating Income (Loss) Loss from operations Nonoperating Income (Expense) [Abstract] Other income (expense), net: Other income (expense), net: Investment Income, Interest Interest income Interest Expense Interest expense Interest expense Interest Expense under the credit agreement Change In Fair Value Of Warrants Change in fair value of warrants Change in fair value of warrants. Gain (Loss) on Extinguishment of Debt Loss on the extinguishment of debt Loss on extinguishment of debt Gain on extinguishment of debt Other Nonoperating Income (Expense) Other expense, net Nonoperating Income (Expense) Total other income (expense), net Weighted Average Number of Shares Outstanding, Basic and Diluted Weighted average common shares outstanding—basic and diluted Weighted average common shares outstanding — basic and diluted Weighted average common shares outstanding—basic and diluted Revenues Net revenue Total revenue Cost of Revenue Cost of goods sold Gross Profit Gross profit Operating Expenses [Abstract] Operating expenses: Selling, General and Administrative Expense Selling, general and administrative Research and Development Expense Research and development Write Off Of Deferred Offering Costs Write-off of deferred offering costs Write-off of deferred offering costs Write-off of deferred offering costs Write-off of deferred offering costs. Operating Expenses Total operating expenses Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Net loss before income taxes Net loss before income taxes Income Tax Expense (Benefit) Income tax (expense) benefit Total income tax expense (benefit) Income tax expense Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss Net income (loss) Net loss Net loss Net loss attributable to Organogenesis Holdings Inc. Net Income (Loss) Attributable to Noncontrolling Interest Net income attributable to non-controlling interest in affiliates Less: Net income attributable to non-controlling interests Net income attributable to non-controlling interest in affiliates Net Income (Loss) Attributable to Parent Net loss attributable to Organogenesis Holdings Inc. Net loss Earnings Per Share, Basic and Diluted Net loss per share attributable to Organogenesis Holdings Inc.—basic and diluted Net loss per share — basic and diluted Net loss per share attributable to Organogenesis Holdings Inc.—basic and diluted Statement of Stockholders' Equity [Abstract] Stock Issued During Period, Value, Other Proceeds from equity financing, net of issuance costs of $270 Stock Issued During Period, Shares, Other Proceeds from equity financing, net of issuance costs of $270 (in shares) Stock Issued During Period, Value, Stock Options Exercised Exercise of stock options Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Exercise of stock options (in shares) Warrants Net Exercised Exercise of stock options Number of Shares Exercised Stock issued During Period Value Warrant Exercise Exercise of common stock warrants Value of stock issued pursuant to exercise of warrant during period Stock issued During Period Share Warrant Exercise Exercise of common stock warrants (in shares) Number of shares of stock issued during the period pursuant to exercise of warrant Stock issued During Period Value Extinguishment Of Debt Issuance of common stock for extinguishment of debt Value of stock issued pursuant to extinguishment of debt during period Stock issued During Period Shares Extinguishment Of Debt Issuance of common stock for extinguishment of debt (in shares) Number of shares of stock issued during the period pursuant to extinguishment of debt Stock Issued During Period, Shares, Issued for Services Common stock issued in exchange for AHPAC shares (in shares) Warrant purchase Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Stock-based compensation expense Stock Issued During Period Value Exercise Of Put Option Notification of exercise of put option of redeemable common stock Stock issued during period, for exercise of put options. Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders Non-controlling interest distributions Stock Issued During Period, Value, Acquisitions Shares issued in connection with NuTech Medical acquisition Stockholders' Equity, Other VIE deconsolidation Adjustments To Additional Paid In Capital Extinguishment of Debt Extinguishment of subordinated notes - affiliates Additional Paid in Capital Extinguishment of Debt Adjustments to Additional Paid in Capital, Warrant Issued Warrants issued in connection with notes payable Noncontrolling Interest, Increase from Subsidiary Equity Issuance Cash contributions from members of affiliates Temporary Equity, Accretion to Redemption Value Accretion of redeemable common shares Less: Accretion of redeemable common shares Adjustments To Additional Paid In Capital Recapitalization Cost Recapitalization costs Additional Paid in Capital Recapitalization Cost Stock Issued During Period, Shares, Acquisitions Shares issued in connection with NuTech Medical acquisition (in shares) Equity Components [Axis] Equity Component [Domain] Redeemable Common Stock Member [Member] Redeemable Common Stock Common Stock [Member] Common Stock Additional Paid-in Capital [Member] Additional Paid-in Capital Parent [Member] Total Organogenesis Holdings Inc Stockholders' Equity [Member] Noncontrolling Interest [Member] Non-controlling Interest in Affiliates [Member] Retained Earnings [Member] Accumulated Deficit Offering Costs Issuance costs Offering costs associated with stock issuance Statement of Cash Flows [Abstract] CONSOLIDATED STATEMENTS OF CASH FLOWS Net Cash Provided by (Used in) Operating Activities [Abstract] Cash flows from operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Depreciation Depreciation Depreciation expense Amortization of Intangible Assets Amortization of intangible assets Non Cash Interest Expense Non-cash interest expense Non-cash interest expense Non Cash Interest Income Non-cash interest income Non-cash interest income Deferred Income Tax Expense (Benefit) Deferred tax (benefit) expense Total deferred tax expense (benefit) Gain (Loss) on Disposition of Property Plant Equipment Loss (gain) on disposal of property and equipment Gain on disposal of property and equipment Impairment Of Notes Receivable Impairment of notes receivable Impairment of notes receivable Provision for Doubtful Accounts Provision recorded for sales returns and doubtful accounts Additions Provision For Inventory Reserve Provision recorded for inventory reserve Amount of expense related to inventory reserve Share-based Compensation Stock-based compensation Fair Value Adjustment of Warrants Change in fair value of warrant liability Fair Value Adjustment of Warrants Fair Value Adjustment Of Interest Rate Swap Change in fair value of interest rate swap Amount of expense (income) related to adjustment to fair value of interest rate swap Fair Value Adjustment Of Forfeiture Rights Changes in fair value of forfeiture rights Fair value adjustment of forfeiture rights. Net Cash Provided by (Used in) Investing Activities [Abstract] Cash flows from investing activities: Payments to Acquire Property, Plant, and Equipment Purchases of property and equipment Proceeds from Sale of Property, Plant, and Equipment Proceeds from disposal of property and equipment Payments to Acquire Businesses, Net of Cash Acquired Acquisition of NuTech Medical, net of cash acquired Consideration variable Interest Entity Deconsolidation VIE deconsolidation variable interest in an entity deconsolidation Net Cash Provided by (Used in) Investing Activities Net cash used in investing activities Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Accounts Receivable Accounts receivable Increase (Decrease) in Inventories Inventory Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other current assets Increase (Decrease) in Accounts Payable Accounts payable Increase Decrease In Accrued Liabilities And Other Current Liabilities Accrued expenses and other current liabilities The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid and other current liabilities Increase Decrease In Accrued Interest Of Affiliate Debt Accrued interest—affiliate debt Amount of interest payable to affiliates Increase (Decrease) in Other Operating Liabilities Other liabilities Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Net Cash Provided by (Used in) Financing Activities [Abstract] Cash flows from financing activities: Proceeds from (Repayments of) Lines of Credit Line of credit borrowings (repayment), net Proceeds From Repayments Of Notes Payable To Related Parties Notes payables—related party borrowings (repayment), net Amount of cash inflow (outflow) from long-term debt supported by a written promise to pay an obligation of related parties Proceeds From Affiliates Long Term Debt Proceeds from long-term debt—affiliates Cash in flow in to the entity by affiliates as long term debt Proceeds from Issuance or Sale of Equity Proceeds from equity financing, net of issuance costs Payments of Stock Issuance Costs Payment of equity issuance costs Repayments of Notes Payable Repayment of notes payable Payments of Distributions to Affiliates Distributions to non-controlling interest in affiliates Proceeds from Related Party Debt Borrowing from affiliates Proceeds from loans Proceeds from Stock Options Exercised Proceeds from the exercise of stock options Proceeds from Contributions from Affiliates Cash contributions from members of affiliates Proceeds from Notes Payable Proceeds from notes payable—master lease Payments for Previous Acquisition Payments of deferred acquisition consideration Payments of Debt Issuance Costs Payment of debt issuance costs Net Cash Provided by (Used in) Financing Activities Net cash provided by financing activities Repayments of Related Party Debt Repayment of debt and debt issuance cost on affiliate debt Payment of Recapitalization Cost Payment of recapitalization costs Payment of Recapitalization Cost Non Cash Rent Expense Income Non-cash rent expense Non-cash rent expense (income). Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Supplemental disclosure of non-cash investing and financing activities: Debt Conversion, Converted Instrument, Amount Fair value of shares issued in connection with investor debt settlement Non Cash Gain On investor Debt Extinguishment Fair value of shares issued in connection with settlement of warrants non cash Gain on investor debt extinguishment Exercise Of Put Option redeemable Common Stock Notice of put option exercise of redeemable common shares Notification of exercise of put option on redeemable common stock Subordinated Notes Converted Warrants Issued Fair value of warrant issued in connection with Subordinated Notes Fair value of warrant issued in connection with Subordinated Notes Notes Payable Converted Warrants Issued Fair value of warrant issued in connection with notes payable Fair value of warrant issued in connection with notes payable Non cash Extinguishment of Subordinated Notes of affiliates Extinguishment of Subordinated Notes—affiliates Extinguishment of Subordinated Notes of affiliates for non acsh Non Cash Accretion Of redeemable Common Stock Accretion of redeemable common stock Accretion of redeemable common stock for non acsh Stock Issued Shares issued in connection with NuTech Medical acquisition Non cash Deconsolidation Of Variable Interest Entities Deconsolidation of variable interest entities, net of cash non cash deconsolidation of variable interest entities Issue Of Deferrd Acquisition Consideration Issuance of deferred acquisition consideration Non Cash issue of deferred Acquisition Consideration Issue Of Contingent Consideration Issuance of contingent consideration forfeiture rights Non cash Issue Of Contingent Consideration Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction Debt issuance costs included in accrued expenses Non Cash Purchase Of Property Plant And Equipment Purchases of property and equipment in accounts payable and accrued expenses Non cash purchase of property plant and equipment. Conversion of Stock, Amount Issued Common stock issued in exchange for AHPAC shares Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Change in cash and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash and restricted cash, beginning of year Cash and restricted cash, end of year Supplemental Cash Flow Elements [Abstract] Supplemental disclosure of cash flow information: